Insulin-like growth factor agonist peptides

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/11 (2006.01) A61K 38/30 (2006.01) C07K 7/00 (2006.01) C07K 7/08 (2006.01) C07K 14/00 (2006.01) C07K 14/47 (2006.01) C07K 16/18 (2006.01) C07K 19/00 (2006.01) G01N 33/68 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2286264

Compounds are provided that inhibit the interaction of an IGF with any (one) of its binding proteins but do not bind to a human IGF receptor. These IGF agonist compounds, which include peptides, are useful to increase serum and tissue levels of active IGFs in a mammal.

L'invention porte sur des composés inhibant l'interaction du facteur de croissance de l'insuline (IGF) avec toutes ses protéines de fixation, mais ne se fixant pas au récepteur humain de l'IGF. Ces composés agonistes de l'IGF, qui incluent des peptides, s'avèrent utiles pour accroître les niveaux d'IGF dans le sérum et les tissus des mammifères.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Insulin-like growth factor agonist peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Insulin-like growth factor agonist peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Insulin-like growth factor agonist peptides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1935285

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.